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ABSTRACT
Background and Objectives: Rapid clinical manifestation/progression of the meningococcal meningitis and lacunae in 
conventional bacteriological test often encourages indiscriminate use of antibiotics much before the etiology is established. 
Accordingly this study was planned to evaluate ctrA PCR for rapid molecular detection. In addition, multiplex PCR and 
sequencing was done for serogroup prediction to provide essential epidemiological and laboratory evidence for decision           
makers of health department of the country for choosing appropriate vaccine and phylogenetic analysis to establish its lineage. 
Materials and Methods: 73 CSF samples, collected from equal number of suspected cases, were investigated by both 
bacteriological (microscopy, culture, LA and drug sensitivity testing) as well as molecular tests i.e. PCR targeting conserved 
ctrA gene, multiplex PCR for serogroup characterization and DNA sequencing.
Results: ctrA PCR revealed sensitivity, specificity, positive predictive value and negative predictive values of 93.15%, 
100%,100%, and 88.23% respectively. Multiplex PCR based genogrouping followed by DNA sequencing, BLAST and 
phylogenetic analysis revealed complete homology with earlier submitted Neisseria meningitidis serogroup A strain 
Z2491 to suggest the sole involvement of only serogroup A in the outbreak. Two strains showed resistance to cefuroxime, 
ciprofloxacin, nalidixic acid. Only one strain showed resistance to ciprofloxacin, emphasizing the need for a constant 
surveillance system. 
Conclusion: These diagnostic molecular tools are of paramount importance in establishing etiology, serogrouping, and 
epidemiological surveillance especially in developing countries like India.
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INTRODUCTION
Meningococcal meningitis is endemic in Delhi and 
sporadic  cases  of  meningococcal  meningitis  have 
occurred in the past (1, 2). In mid 2008, Delhi and 
its  adjoining  national  capital  region  (NCR)  were 
badly affected by sudden surge in sporadic cases of 
meningococcal meningitis. Meningococcal meningitis 
is  still  diagnosed  mainly  by  clinical  features  and 
response  to  antibiotic  treatment.  However,  WHO 
preventive strategy for such outbreak suggest early 
and accurate detection to initiate specific treatment 
and rapid implementation of mass vaccination using 
an appropriate polysaccharide vaccine, the success 
of which is based on serogroup identification (3). In 
view of this, urgent need for establishing etiology, 
serogroup prediction has been felt as conventional 
diagnosis  based  on  culture  and  latex  agglutination 
have several lacunae reported earlier (4- 7).
Accordingly this  study  was  done with the aims of (i) 
evaluating ctrA gene for rapid molecular identification 
of N. meningitidis due to its conserved nature among 
strains  of  N.  meningitidis  (ii)  Drug  susceptibility 
testing  of  the  isolates  obtained  in  culture  (iii) 74 NEGI   ET AL .                                                                                                                            IRAN. J. MICROBIOL. 2 (2) : 73-79
Genogrouping of N.meningitidis  by multiplex PCR 
to target orf-2  of myn B  gene for serogroup A and   
sialyltransferase (sia D) gene for serogroup B,C, Y 
and W135 characterization. 
MATERIALS  AND  METHODS
Seventy-three  CSF  samples  were  obtained  from 
equal number of probable meningococcal meningitis 
cases (as per WHO clinical case definition) admitted 
in  different  hospitals  of  Delhi  for  the  period  of 
meningococcal meningitis outbreak from March to 
July, 2008 (3). In addition, few Gram positive and Gram 
negative bacterial strains other than N.meningitidis 
were  listed  as  Citrobacter  freundii,  Enterobacter 
aerogenes,  E.coli,  Klebsiella  pneumoniae,  Proteus 
vulgaris,  Pseudomonas  aeruoginosa,  Salmonella 
typhi, Salmonella paratyphi, Enterococcus faecalis, 
Staphylococcus aureus, Staphylococcus epidermidis, 
Streptococcus pneumoniae, Streptococcus pyogenes, 
Streptococcus viridians. Fifteen CSF samples obtained 
from  subjects  suffering  from  conditions  other  than 
acute pyogenic meningitis (5 tuberculous meningitis, 
and 10 cases of viral encephalitis) were also used in 
the study as negative controls. The clinical isolates of 
N.meninigitidis ATCC  serogroup A  strain  (13077), 
serogroup B (ATCC13090), serogroup C (ATCC13102) 
were obtained from ARI (Acute Respiratory Infection) 
laboratory  of  NCDC  (National  Centre  for  Disease 
Control). 
Microscopy. The CSF samples were centrifuged 
for  20  minutes  at  1500-2000  rpm  and  smear  was 
prepared from the deposit without spreading the fluid. 
The air dried and heat fixed smear was stained by 
Gram staining and examined microscopically using 
100X oil immersion lens. N.meningitidis bacilli were 
seen as intra and/or extracellular gram negative coffee 
bean shaped diplococci.
Culture  &  biochemical  confirmation.  The 
centrifuged  deposit  of  the  CSF  was  inoculated  in 
chocolate and blood agar. Culture plates were incubated 
at  37OC  in  5%  CO2  atmosphere  for  24-48  hours. 
Colonies of N.meningitidis   appeared as small (about 
1 mm in diameter), gray colored, translucent, round, 
and  convex,  bluish  grey  with  a  smooth  glistening 
surface.  Colonies  were  biochemically  confirmed 
for N.meningitidis by testing for oxidase production 
(positive result) and testing for carbohydrate utilization 
(positive reaction for glucose, maltose and negative 
reaction for sucrose and lactose).
 Latex agglutination (LA). The antigen detection in 
CSF was carried out by latex agglutination test using 
commercially available kit (LA Meningitis kit, Bio 
Rad, USA) following the instructions given in the kit 
brochure. Briefly, one drop of CSF (50 µl) after heat 
inactivation  (100OC  for  5  minutes)  was  suspended 
in a drop of specific latex antisera for serogroup A, 
B, C, D, W135, Y and mixed thoroughly. A visible 
agglutination  within  10  minutes  was  recorded  as 
positive for the specific serogroup.
Antimicrobial  susceptibility  testing.  Culture 
isolates were subjected to drug susceptibility testing 
against penicillin G, amikacin, ampicillin, vancomycin, 
nalidixic acid, chloramphenicol, cefotaxime, ceftriaxone, 
imipenem,  ofloxacin,  moxifloxacin,  cefuroxime  and 
ciprofloxacin  by  E-test  (MIC  method)  strips  (AB 
BIODISK,  Sweden)  using  break  points  recently 
recommended by NCCLS/CLSI (8).
Molecular  identification  and  serogroup 
characterization. Genomic DNA was purified from 
200µl of each CSF sample using QIAmp DNA Mini 
Kit  (QIAGEN  Inc.,  Chatsworth,  Calif)  as  per  the 
manufacturer’s protocol. 
For identification and serogroup characterization, 
oligonucleotide primers to  specific sequences were 
used as described earlier (9, 10). However, thermal 
cycling profile was changed to certain extent from 
earlier studies to obtain optimal result (Table 1). For 
assessing  sensitivity  of  ctrA  PCR  assay,  bacterial 
culture in the logarithmic phase of growth (optimal 
density  at  600  nm  ≈0.7  to  0.8)  was  diluted  in 
phosphate  buffered  saline.  Each  two  fold  dilution 
was tested in PCR assays to determine the minimal 
number  of  colony  forming  units  (cfu)  that  could 
be detected. CFU was estimated by standard plating 
procedure (11, 12).
DNA Sequencing. PCR myn B gene amplicon’s 
products  were  purified  by  precipitation  with  3  M 
sodium  acetate  and  isopropanol.  Then,  automated 
nucleotide  sequencing  was  performed  using  Big 
Dye-Terminator  Cycle  Sequencing  kit  (Applied 
Biosystem, USA) using 10 to 50 ng of PCR product 
and 2-3 pmol of sequencing  primer. PCR amplicons 
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primers.  Extension  products  were  purified  by  3M 
sodium  acetate  and  ethanol  precipitation.  Purified 
extension products were resuspended in 12 µl of Hi 
di formamide and vortexed for few seconds. Then, 
they were kept at 96oC for 3 min and subjected to 
rapid chilling by keeping on ice for 15 min before 
loading  onto  a  capillary  DNA  sequencer  (ABI 
310  Genetic  Analyzer,  Applied  Biosystem,  USA). 
Sequences were assembled with the auto assembler 
DNA sequence software version 2.0, and consensus 
sequences were obtained using Seqed DNA software 
(ABI). Consensus sequences representative of each 
variant  were  then  analyzed  with  the  Gen  Bank 
BLASTN  search.  Multiple  sequence  alignments 
(MSA) were done using CLUSTAL W. Phylogenetic 
analysis was performed by MEGA 4 software using 
reference sequence which were previously reported 
and  submitted  in  gene  data  bank  (AF019760.1, 
AL157959.1, AY234202.1, AY234203.1, AY234204.1, 
AY234205.1,AY281049.1, NC003116.1).
Statistical analysis was done by chi square (χ2) test 
(13).
RESULTS
 All  15 CSF samples of nonmeningococcal origin 
were  found  negative  by  all  four  tests  discussed 
depicting  100%  specificity  for  smear  microscopy, 
culture, LA and ctrA PCR.  ctrA PCR was also found 
negative in a battery of bacterial species other than       
N. meningitidis showing its high specificity. 
Smear  microscopy,  culture  and  LA  test  showed 
the sensitivity of 15.06 % (11/73), 6.8 % (5/73) and 
86.30% (63/73) respectively. In comparison, the ctrA 
PCR test (Fig. 1) with sensitivity of 93.15% (68/73) 
was  found  to  be  much  more  sensitive  than  smear 
Purpose Gene target Oligonucleotide primer 
sequence
PCR component 
concentration
Thermal cycling Amplicon size in 
2% Agarose gel
Identification ctrA
5’ccagcggtattgtttggtggt3’
5’caggcggcctttaataatttc3’
10 pmole each primer, 2.5mM 
MgCl2,1XPCRbuffer,200µM 
deoxynucleoside triphosphate,
1.25 U Taq  polymerase 
(PerkinElmer)
950C /4min, 35cycle  
950C/10 sec,550C 
30sec and1 cycle at 
720C/ 7min
177 bp
Serogroup 
characterization 
by multiplex 
PCR
Orf-2of myn B gene 
for Serogroup A
5’cgcaataggtgtatatattcttcc3’
5’cgtaatagtttcgtatgccttctt3’
0.3 µM each primer,5mM 
MgCl2, 1X PCR buffer, 
200µM,1U Taq polymerase 
(Perkin Elmer)
1cycle(940C/3min,5
50C/30sec,720C),35 
cycle  (920C/40sec,55
0C/30sec,720/20sec),1
cycle (720C/10min)
400 bp
SiaD (serogroup B)
5’cgtaatagtttcgtatgccttctt3’
5’gcatgctggaggaataagcattaa3’
450 bp
SiaD (serogroup C)
5’gcatgctggaggaataagcattaa3’
5’tcaaatgagtttgcgaatagaaggt3’
250 bp
SiaD 
(serogroup W135)
5’cagaaagtgagggatttccata3’
cacaaccattttcattatagttactgt3’
120 bp
Sia D (Y)
5’ctcaaagcgaaggctttggtta3’
ctgaagcgttttcattataattgctaa3’
120 bp
Table 1. Oligonucleotides primers used in this study.
Fig. 1. Amplified product of 177bp of ctrA gene from meningococcal meningitis suspected cases.
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Fig. 1. Amplified product of 177bp of ctrA gene from meningococcal meningitis suspected cases.
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Fig.  2.  Multiplex  PCR  showing  amplification  of  400bp  region  of  orf-2  of  myn  B  gene  specific  for 
serogroup A from clinical samples of CSF. Lane 5 from left is the negative control (ddH2O). 100bp size 
marker (Perkin Elmer) are indicated in base pair at the left. Electrophoresis was done on a 2% agarose 
gel. 
200bp
177bp
400bp76 NEGI   ET AL .                                                                                                                            IRAN. J. MICROBIOL. 2 (2) : 73-79
examination,  culture  and  LA  test  on  applying  chi 
square test (χ2) at 95% confidence level (p < 0.05) . PCR 
revealed a sensitivity of less than 5 CFU. All the culture 
isolates obtained were confirmed as N. meningitidis 
with the biochemical tests mentioned. We compared 
the sensitivity of PCR test vis a vis three different 
tests  i.e.,  smear  examination,  culture  and  LA  test 
individually as well as in combination (Table 2).
The sensitivity of detection of N. meningitidis in 
smear  positive  samples  by  ctrA  PCR  approached 
100%, whereas even in smear negative specimens, 
it had a sensitivity of 80.64%. 100% sensitivity  of 
ctrA  PCR  was  observed  for  culture  positive  samples, 
whereas  in  culture  negative  samples,  82.35%  of 
sensitivity was observed. In LA test positive samples, 
61 samples were found positive by ctrA PCR test with 
sensitivity of 96.82%. In LA test negative samples, 
50% of samples showed positive PCR result. Among 
58 smear or LA positive but culture negative samples, 
56 samples were found positive by ctrA PCR test with 
sensitivity of 96.5%. In 5 out of 10 CSF samples, 
which  were  found  negative  by  conventional  test 
used, only ctrA PCR gave the confirmatory result.   
Positive and negative predictive value of ctrA PCR 
was recorded as 100% and 88.23% respectively.
Two culture isolates showed susceptibility to all 
commonly  used  drugs  i.e.  penicillin  G,  amikacin, 
ampicillin,  vancomycin,  nalidixic  acid,  chloram-
phenicol,  ciprofloxacin,  cefotaxime,  ceftriaxone, 
imipenem, ofloxacin, moxifloxacin and cefuroxime. 
However,  three  isolates  showed  resistance  to  one 
or  more  antibiotic. Two strains showed resistance to 
cefuroxime  (MIC  16-17.4  µg/mL),  ciprofloxacin 
(MIC 4.5-6 µg/mL), nalidixic acid (MIC 32-48 µg/mL), 
and one strain showed resistance to ciprofloxacin (MIC 
6 µg/mL) only. 
Multiplex  PCR  correctly  characterized  the 
serogroup of all N. meningitidis positive CSF samples 
found by ctrA PCR (Fig. 2). Multiplex PCR results 
of serogroup determination was found in accordance 
with  the  result  of  LA  test. All  strains  were  found 
belonging  to  serogroup A,  giving  400bp  amplicon 
specific  for  orf-2  of  myn  B  gene  characterizing 
serogroup A,  to  support  the  fact  of  prevalence  of 
Test/Result category (No.) PCR Result Sensitivity of PCR test (%)
positive negative
Smear microscopy positive (11) 11 0 100%
Smear  microscopy negative (62) 50 12 80.64%
Culture positive (5) 5 0 100%
Culture negative (68) 56 12 82.35%
LA positive (63) 61 2 96.82%
LA negative (10) 5 5 50.0%
Smear and/or LA +ve but culture –ve (58) 56 2 96.5%
Smear or LA or culture +ve (63) 61 2 96.82%
Smear, culture& LA negative (10) 5 5 50.0%
Table 2. Sensitivity of ctr A PCR test with regard to three different tests, individually as well as in combination.
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serogroup A in India. In Phylogenetic analysis using 
MEGA  4  software,  all  sequences  showed  similar 
lineage pattern corresponding to single node origin 
with maximum match with earlier submitted sequence 
of N. meningitidis serogroup A strain Z2491.
DISCUSSION
During the 2008 meningococcal meningitis outbreak, 
similar  to  which  Delhi  had  witnessed  at  regular 
intervals in the past, the need for rapid and accurate 
molecular  diagnostic  test  was  felt  for  identification 
and  serogroup  characterization  to  initiate  specific 
chemotherapy  and  reduce  morbidity  and  mortality. 
This would also provide substantial information to help 
decision makers of the health department of the country 
to use best epidemiological and laboratory evidence of 
serogroup involved in the outbreak for choosing the 
most appropriate vaccine (1, 2, 14).  Laboratory based 
surveillance is  key to efficient control of this problem. 
The laboratory diagnosis of meningoccal disease is 
usually carried out by conventional methods which 
lack sensitivity specially in antibiotic treated subjects. 
The  majority  of  notified  cases  of  meningococcal 
disease in India are based only on clinical grounds 
without confirmation of the etiology by a laboratory 
technique. In this study, we have standardized a single 
tube, single primer set assay developed for the rapid 
detection of N. meningitidis in CSF samples within 
3 hours of sample received. Rapid turnaround time 
with high positive and negative predictive value of 
ctrA PCR may provide clinician the vital diagnostic 
information for early and effective treatment of patient 
to curb the spreading of the disease at initial stages.
The  conserved  ctrA  gene  was  chosen  for  the 
standardization & evaluation of PCR assay specific 
for  N.  meningitidis  detection. This  gene  codes  for 
conserved outer membrane protein of N. meningitidis 
believed  to  be  an  ABC  (ATP-binding  cassette) 
transporter (9). ctrA gene  was earlier demonstrated 
to occurs exclusively in N. meningitidis and not in 
other pathogenic or nonpathogenic Neisseria species, 
thus providing a good candidate for a N. meningitidis 
specific DNA based assay (15).
Optimal  PCR  results  were  obtained  with  a  slight 
modification in thermal cycling parameter used earlier by 
Lansac et al. (2000), by giving 35 cycles and denaturation 
time of 95oC for 10 sec. which gave the optimal result 
in our study. Lansac et al. obtained  optimal results with 
30 cycles and denaturation time of 95oC for 1 sec. The 
justified reason could be lab to lab variation which were 
also supported by earlier studies (9).
As evident from the results, smear microscopy and 
culture lacked sensitivity for detection of N. meningitidis 
in clinical samples. ctrA PCR test with an overall 
sensitivity of 93.15% showed a significant difference 
over conventional tests in detection of N. meningitidis 
in the clinical samples of CSF (p<0.05). However, 
unusual low sensitivity in  culture could be attributed 
most probably to fear psychosis associated with the 
disease causing the antibiotic treatment to be commenced 
as soon as possible to prevent the mortality and also 
some administrative delay in sending CSF samples 
to NCDC for laboratory testing. So, ctrA PCR would 
further  be  useful  in  outbreak  circumstances  where 
prior  antibiotic  treatment  is  inevitable.  ctrA  PCR 
detected N. meningitidis in all culture proven cases 
and in 56/58 samples in smear or antigen detection 
(LA) positive cases. The failure of ctrA PCR in two 
LA proven cases could probably be due to the presence 
of  inhibitory substances in the specimen. Our ctrA 
PCR result showed the sensitivity, specificity, positive 
and negative predictive value of 93.15, 100, 100 and 
88.23% which  were comparable with earlier studies 
of  Chakrabarti  et  al.  (2009)  showing  79.24,  97.6, 
89.36, 94.88, Failace et al. (2005) showing 88.1, 99, 
98.7, 90.1, Richardson et al. (2003) showing 97, 99.6, 
99.6,  97%,  Baethgen  et  al.  (2003),  showing  88.2, 
100, 100, 79.4%, Taha et al. (2000) showing 93, 96, 
98, 86% sensitivity, specificity, positive and negative 
predictive value respectively (4, 7, 10, 16, 17). Pedro 
et al. 2007 showed 96% sensitivity  of their PCR 
in diagnosis of meningococcal meningitis in Brazil 
(6). Filippis et al. (2005) showed 100% sensitivity 
and 78.4% specificity (5). In 2005 study of Taha et 
al., 11 meningococcus reference centre located in 11 
different European countries showed mean sensitivity 
and specificity of 89.7 and 92.7% by PCR (18). Major 
advantage of ctrA PCR over conventional test has 
been seen in samples undiagnosed by conventional 
test as from a total of 10 samples declared negative 
by all conventional test, 5 were found positive for 
N. meningitidis by ctrA PCR only with sensitivity 
of  50%  in  such  cases. This  percentage  was  found 
higher than that of Taha et al. whose studies found 
35% positivity and 31% obtained by New combe et al. 
1996 using PCR in suspected cases of meningococcal 
disease (10, 19).
Various  other  target  genes  were  also  used  in  the       
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insertion sequence IS1106 was shown to provide a rapid 
and sensitive assay for the diagnosis of meningococcal 
meningitis in patients with negative findings in culture 
tests due to prior antibiotic treatment. However false 
positive  diagnosis  of  meningococcal  infection  by 
the  IS1106  PCR  has  been  reported  with  probable 
reason of their inherent genetic mobility of insertion 
sequences which lead to their transfer among bacterial 
species and genera (16, 20). PCR targeting 16S and/
or 23S ribosomal RNA genes showed sensitivity and 
specificity varied from 80 to 95% and the detection 
limit in agarose gels ranged from 30 to 3 CFUs per 
reaction tube (21-23).The sensitivity level achieved 
with our ctrA PCR assay are less than 5 CFUs.
Protocols based on real time PCR have been used 
for  simultaneous  detection  of  N.  meningitidis,  H. 
influenzae  and  Streptococcus  pneumoniae  using 
ctrA, bexA and ply gene targets, respectively (24). 
This methodology promises to be the ultimate PCR 
diagnosis, but it is still too expensive to be applied in 
a public health laboratory. 
Though the three isolates showed resistance to one 
or other drugs, their result could not corroborate any 
drug resistant pattern in the community. However,  the 
result emphasizes the need of constant surveillance 
system  to  monitor  the  emergence  and  spread  of 
antimicrobial drug resistant strains.
Genogrouping  of  N.  meningitidis  has  been  of 
great  epidemiological  importance.  Genogrouping 
by multiplex PCR found that all ctrA PCR positive 
findings    have  amplified  400bp  orf-2  region  of 
myn  B  gene,  confirming  the  sole  involvement  of 
serogroup A in this epidemic and compounding the 
fact that serogroup A strains are responsible for major 
epidemic and pandemics of meningococcal disease. 
Multiplex PCR should have a great implication in 
opening new possibilities of more reliable surveillance 
over  conventional  technique  based  surveillance. 
DNA  sequencing,  comparative  BLAST  result  and 
phylogenetic  analysis  using  MEGA  4  revealed 
complete homology of meningitidis strains involved 
in this outbreak with earlier submitted sequence of 
N.meningitidis serogroup A strain Z2491 to suggest 
the  sole  involvement  of  only  serogroup A  in  this 
outbreak. We conclude by saying that these two steps 
approach (identification of N.meningitidis followed by 
genogrouping) seems to provide rapid identification 
of etiological agent and characterizing the serogroup, 
leading to fast track management of meningococcal 
outbreak  situations  where  administering  antibiotic 
treatment is a prerequisite condition for the clinician 
for controlling mortality and morbidity which often 
led culture techniques less sensitive for its diagnosis.
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